James Peyer is the Chief Executive Officer and Co-Founder of Cambrian Biopharma. He also serves as the Chairman of the Board of Sensei Biotherapeutics and board and executive roles across Cambrianβs pipeline. He has spent his entire life dedicated to the mission of finding ways of preventing people from getting diseases like cancer and Alzheimerβs instead of waiting for people to get sick.
Nathaniel David has co-founded four biotechnology companies that have collectively raised over $2 billion in financing and have given rise to three IPOs, two M&A acquisitions, and four FDA-approved medicines (ALOGLIPTIN, TRELAGLIPTIN, ZEMDRI, and KYBELLA). Nathaniel holds 46 allowed patents in fields as far flung as nanovolume crystallography, antibiotic resistance, aesthetic medicine, and cellular senescence.
Kristen Fortney is the co-founder and CEO of BioAge, a clinical-stage biotechnology company developing a pipeline of treatments to extend healthy lifespan by targeting the molecular causes of aging. The company uses its discovery platform, which combines quantitative analysis of proprietary longitudinal human samples with detailed health records tracking individuals over the lifespan, to map out the key molecular pathways that impact healthy human aging.
Moderator Dina Radenkovic is a Partner at SALT Fund. Dina is an academic doctor and medical technology entrepreneur. She qualified with a dual degree in medicine and physiology from UCL Medical School. Dina is a co-founder and CSO of Hooke, an elite longevity research clinic, in collaboration with the Buck Institute for Aging.
SALT New York is a global thought leadership and networking forum at the intersection of finance, technology and public policy. Over the course of three days, leading investors, creators and thinkers will take the stage in support of SALTβs mission: empowering big ideas.
To learn more about SALT, visit https://www.salt.org/
Listen and subscribe on the platform of your choice:
YouTube: https://www.youtube.com/c/SALTTube
Apple: https://podcasts.apple.com/us/podcast...
Spotify: https://open.spotify.com/show/3HGRcJU...
Follow SALT on social media:
Twitter: https://twitter.com/SALTConference
Instagram: https://www.instagram.com/salt/
LinkedIn: https://www.linkedin.com/company/salt...
Developed, created and produced by SALT Venture Group, LLC.
Nathaniel David has co-founded four biotechnology companies that have collectively raised over $2 billion in financing and have given rise to three IPOs, two M&A acquisitions, and four FDA-approved medicines (ALOGLIPTIN, TRELAGLIPTIN, ZEMDRI, and KYBELLA). Nathaniel holds 46 allowed patents in fields as far flung as nanovolume crystallography, antibiotic resistance, aesthetic medicine, and cellular senescence.
Kristen Fortney is the co-founder and CEO of BioAge, a clinical-stage biotechnology company developing a pipeline of treatments to extend healthy lifespan by targeting the molecular causes of aging. The company uses its discovery platform, which combines quantitative analysis of proprietary longitudinal human samples with detailed health records tracking individuals over the lifespan, to map out the key molecular pathways that impact healthy human aging.
Moderator Dina Radenkovic is a Partner at SALT Fund. Dina is an academic doctor and medical technology entrepreneur. She qualified with a dual degree in medicine and physiology from UCL Medical School. Dina is a co-founder and CSO of Hooke, an elite longevity research clinic, in collaboration with the Buck Institute for Aging.
SALT New York is a global thought leadership and networking forum at the intersection of finance, technology and public policy. Over the course of three days, leading investors, creators and thinkers will take the stage in support of SALTβs mission: empowering big ideas.
To learn more about SALT, visit https://www.salt.org/
Listen and subscribe on the platform of your choice:
YouTube: https://www.youtube.com/c/SALTTube
Apple: https://podcasts.apple.com/us/podcast...
Spotify: https://open.spotify.com/show/3HGRcJU...
Follow SALT on social media:
Twitter: https://twitter.com/SALTConference
Instagram: https://www.instagram.com/salt/
LinkedIn: https://www.linkedin.com/company/salt...
Developed, created and produced by SALT Venture Group, LLC.
-
- 1
Francisco Gimeno - BC Analyst Biotechnology is already changing the world we live, our own lives. CRISPR tech one of its results. It totally fits inside the disruption brought by the 4th IR, together with other new techs. New medicines, tinkering with cells, fighting against cancer or Alzheimer, or sickle cell disease, is just the beginning. One of the main projects is how to treat ageing, or even stopping (science fiction realm as it the science is now). The future is open to wonders.